Light therapy offers new hope for prostate cancer patients
NCT ID NCT06807359
First seen Jan 06, 2026 · Last updated May 21, 2026 · Updated 20 times
Summary
This study tests a new treatment for prostate cancer that hasn't spread. It uses a special drug activated by light to destroy cancer cells. About 43 men will take part. The goal is to see if it's safe and effective, with follow-up over 18 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Klinik für Urologie, Universitätsklinikum Köln
RECRUITINGCologne, 50937, Germany
Contact
-
Klinik und Poliklinik für Urologie, Universitätsmedizin Rostock
RECRUITINGRostock, Germany
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
Contact
Conditions
Explore the condition pages connected to this study.